Volume : 10, Issue : 05, May – 2023
Title:
47.A REVIEW ON PHARMACEUTICAL NANOCRYSTALS
Authors :
V. F. Sony*, Mrs. Aparna. P, Akash Jayaprakash, Dr. Prasobh. G. R
Abstract :
About 40% of drugs on the market have problems with poor solubility in water, and it has been found that 70% of the molecules in water are practically insoluble in water. Nanocrystals can be prepared by top-down, bottom-up and combinatorial methods. Many patented products such as Nanocrystals®, DissoCubes®, NANOEDGE® and SmartCrystals® are based on our plans. The reduction in size leads to instability of the nanocrystalline system and Austenitic maturation to occur. Nanosuspension can be converted to a steady state by performing various processes, such as freeze drying, spray drying, pelleting, and pelleting to prevent solid state particles from aggregating. These techniques are known for their scalability and continuous nanocrystal formation. Nanocrystals can be characterized using Scanning Electron Microscopy, Transmissive Electron Microscopy, Atomic Force Microscopy, Differential Scanning Calorimetry, Fourier Transform Infrared Spectroscopy, Powder X-ray Diffraction, and Photon Correlation Spectroscopy. One of the biggest advantages of nanocrystals is their wide range of applications such as oral administration, ocular administration, pulmonary administration, transdermal administration, intravenous administration and target (brain and tumour target).
KEYWORDS: Nanocrystals, Ostwald ripening, Bioavailability, Pearl milling, Lyophilisation
Cite This Article:
Please cite this article in press V. F. Sony et al,. A Review On Pharmaceutical Nanocrystals., Indo Am. J. P. Sci, 2023; 10 (05).
Number of Downloads : 10
References:
1. Volkmar Weissig, Tracy .K. Pettinger, Nicole Murdock. Nanopharmaceuticals (part 1): products on the market; International journal of nanomedicine, September 2014; 15(9): 4357-73.
2. Ram .B. Gupta, Uday .B. Kompella. Nanoparticle Technology for Drug Delivery; 2006; 1st edition.
3. Deepak Thassu, Michel Deleers, Yashwant Vishnupant Pathak. Nano particulate Drug Delivery Systems, CRC Press; 2007.
4. Rajan Jog, Diane .J. Burgess. Pharmaceutical amorphous nanoparticles; Journal of pharmaceutical sciences, January 2017; 106(1): 39-65.
5. Jens-Uwe. A. H. Junghanns, Rainer. H. Müller. Nanocrystal technology, drug delivery and clinical applications; International journal of nanomedicine, 2008; 3(3): 295-309.
6. Roberto Censi, Piera Di Martino. Polymorph impact on the bioavailability and stability of poorly soluble drugs; Molecules, October 2015; 20(10): 18759-76.
7. Lei Gao, Guiyang Liu, Jianli Ma, Xiaoqing Wang, Liang Zhou, Xiang Li, Fang Wang. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs; Pharmaceutical Research, February 2013; 30(2): 307-24.
8. Annika Tuomela. Nanocrystals for Drug Delivery Applications. 2015.
9. Cornelia. M. Keck, Rainer. H. Müller. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation; Europran Journal of Pharmaceutics and Biopharmaceutics, 2006; 62(1): 3-16.
10. Abhijit. A. Date, V. B. Patravale. Current strategies for engineering drug nanoparticles; Current Opinion in Colloid and Interface Science, 2004; 9(3-4): 222-235.
11. Ibrahim Khan, Khalid Saeed, Idrees Khan. Nanoparticles: Properties, applications and toxicities; Arabian Journal of Chemistry, November 2017; 12(7): 908-931.
12. Yingchao Li, Lei Dong, Ai Jia, Xinming Chang, Hui Xue. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine; International Journal of Biological Macromolecules, May 2006; 38(3-5): 296-309.
13. Du J, Li X, Zhao H, et al. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. International Journal of Pharmaceutics, November 2015; 495(2): 738-749.
14. Dianrui Zhang, Tianwei Tan, Lei Gao, Wenfa Zhao, Peng Wang. Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies. Drug Deveopment and Industrial Pharmacy, May 2007; 33(5): 569-575.
15. Bernard Van Eerdenbrugh, Guy Van den Mooter, Patrick Augustijns. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. International Journal of Pharmaceutics, November 2008; 364(1): 64-75.
16. Jennifer Scalf, Paul West. Part I: Introduction to nanoparticle characterization with AFM; Pacific Nanotechnology advancing nanotechnology, January 2006.
17. Sanjay Bansal, Rachna Kumria. Nanocrystals: Current Strategies and Trends; International Journal of Research in Pharmaceutical and Biomedical Sciences, January 2012; 3(1): 407- 419.
18. H. G. Brittain, S. J. Bogdanowich, D. E. Bugay, J. DeVincentis, G. Lewen, A. W. Newman. Physical Characterisation of Pharmaceutical Solids; Pharmaceutical Research, August 1991; 8(8): 963-973.
19. R. Bruno, Rod McIlwrick. Microfluidizer processor technology for high performance particle size reduction, mixing and dispersion; European Journal of Pharmaceutics and Biopharmaceutics, 2001.
20. Barret. E. Rainbow. Nanosuspensions in Drug Delivery; Nature Reviews Drug Discovery, 2004; 3: 785-796.
21. C. Jacobs, O. Kayser, R. H. Müller Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide; Inernational Journal of Pharmaceutics, March 2000; 196(2): 161-164.
22. Fichera, M.A., Keck, C.M. Müller, R.H. Nanopure Technology – Drug Nanocrystals for the Delivery of Poorly Soluble Drugs, in Particles. Orlando, 2004
23. Kipp James. E, Tak Wong Joseph Chung, Doty Mark, Rebbec Christine. L. Microprecipitation method for preparing submicron suspensions. US Patent 6607784; USA. 2002
24. Jiahui Hu, Keith. P. Johnston, Robert. O. Williams 3rd. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs; Drug Development and Industrial Pharmacy, March 2004; 30(3): 233-245.
25. M. A. Kassem, A. A. Abdel Rahman, M. M. Ghorab, M. B. Ahmed, R. M. Khalil. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. International Journal of Pharmaceutics, August 2007; 340(1-2): 126-133.